Melief CJ - Search Results

1

Differential kinetics of antigen-specific CD4+ and CD8+ T cell responses in the regression of retrovirus-induced sarcomas.

Schepers K, Toebes M, Sotthewes G, Vyth-Dreese FA, Dellemijn TA, Melief CJ, Ossendorp F, Schumacher TN. Schepers K, et al. Among authors: melief cj. J Immunol. 2002 Sep 15;169(6):3191-9. doi: 10.4049/jimmunol.169.6.3191. J Immunol. 2002. PMID: 12218137

2

Genomic organization and chromosomal localization of the human CD27 gene.

Loenen WA, Gravestein LA, Beumer S, Melief CJ, Hagemeijer A, Borst J. Loenen WA, et al. Among authors: melief cj. J Immunol. 1992 Dec 15;149(12):3937-43. J Immunol. 1992. PMID: 1334106

3

Role of LFA-1 and VLA-4 in the adhesion of cloned normal and LFA-1 (CD11/CD18)-deficient T cells to cultured endothelial cells. Indication for a new adhesion pathway.

Vennegoor CJ, van de Wiel-van Kemenade E, Huijbens RJ, Sanchez-Madrid F, Melief CJ, Figdor CG. Vennegoor CJ, et al. Among authors: melief cj. J Immunol. 1992 Feb 15;148(4):1093-101. J Immunol. 1992. PMID: 1371131

4

Both LFA-1-positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activation.

Van de Wiel-van Kemenade E, Te Velde AA, De Boer AJ, Weening RS, Fischer A, Borst J, Melief CJ, Figdor CG. Van de Wiel-van Kemenade E, et al. Among authors: melief cj. Eur J Immunol. 1992 Jun;22(6):1467-75. doi: 10.1002/eji.1830220620. Eur J Immunol. 1992. PMID: 1376259 Free article.

5

Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses.

De Bruijn ML, Nieland JD, Schumacher TN, Ploegh HL, Kast WM, Melief CJ. De Bruijn ML, et al. Among authors: melief cj. Eur J Immunol. 1992 Nov;22(11):3013-20. doi: 10.1002/eji.1830221137. Eur J Immunol. 1992. PMID: 1425925

6

A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part I: Clinical aspects.

Vlasveld LT, Rankin EM, Hekman A, Rodenhuis S, Beijnen JH, Hilton AM, Dubbelman AC, Vyth-Dreese FA, Melief CJ. Vlasveld LT, et al. Among authors: melief cj. Br J Cancer. 1992 May;65(5):744-50. doi: 10.1038/bjc.1992.157. Br J Cancer. 1992. PMID: 1586602 Free PMC article. Clinical Trial.

7

Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.

De Bruijn ML, Schumacher TN, Nieland JD, Ploegh HL, Kast WM, Melief CJ. De Bruijn ML, et al. Among authors: melief cj. Eur J Immunol. 1991 Dec;21(12):2963-70. doi: 10.1002/eji.1830211210. Eur J Immunol. 1991. PMID: 1660811

8

Peptide selection by MHC class I molecules.

Schumacher TN, De Bruijn ML, Vernie LN, Kast WM, Melief CJ, Neefjes JJ, Ploegh HL. Schumacher TN, et al. Among authors: melief cj. Nature. 1991 Apr 25;350(6320):703-6. doi: 10.1038/350703a0. Nature. 1991. PMID: 1708852

9

T-cell immunotherapy of cancer.

Melief CJ, Kast WM. Melief CJ, et al. Res Immunol. 1991 Jun-Aug;142(5-6):425-9. doi: 10.1016/0923-2494(91)90042-h. Res Immunol. 1991. PMID: 1754715 Review.

10

Mutations in the major histocompatibility complex class I antigen-presenting groove affect both negative and positive selection of T cells.

Jacobs H, Von Boehmer H, Melief CJ, Berns A. Jacobs H, et al. Among authors: melief cj. Eur J Immunol. 1990 Oct;20(10):2333-7. doi: 10.1002/eji.1830201024. Eur J Immunol. 1990. PMID: 2147006

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

543 results

Search Page